Gary Schaer to Treatment Outcome
This is a "connection" page, showing publications Gary Schaer has written about Treatment Outcome.
Connection Strength
0.387
-
Therapeutic angiogenesis for the management of refractory angina: current concepts. Cardiovasc Ther. 2011 Dec; 29(6):e1-e11.
Score: 0.047
-
Clinical and angiographic outcomes of cardiac transplant patients treated with intracoronary beta-radiation for in-stent restenosis: a case series. Cardiovasc Radiat Med. 2004 Oct-Dec; 5(4):162-5.
Score: 0.032
-
Intracoronary beta brachytherapy as a treatment option for high-risk refractory in-stent restenosis; Compassionate use. Cardiovasc Radiat Med. 2004 Jan-Mar; 5(1):9-14.
Score: 0.031
-
Predictors of late cardiac events following treatment with Sr-90 beta-irradiation for instent restenosis. Cardiovasc Radiat Med. 2003 Jan-Mar; 4(1):7-11.
Score: 0.029
-
Utility of Guide Extension Catheter for Rotational Atherectomy Through a?LIMA?Graft. JACC Cardiovasc Interv. 2022 01 10; 15(1):e1-e2.
Score: 0.026
-
PreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients With Left Ventricular Dysfunction Post STEMI. Circ Res. 2017 Jan 20; 120(2):324-331.
Score: 0.019
-
The RENEW Trial: Efficacy and Safety of Intramyocardial Autologous CD34(+) Cell Administration in Patients With Refractory Angina. JACC Cardiovasc Interv. 2016 08 08; 9(15):1576-85.
Score: 0.018
-
Beneficial effects of RheothRx injection in patients receiving thrombolytic therapy for acute myocardial infarction. Results of a randomized, double-blind, placebo-controlled trial. Circulation. 1996 Aug 01; 94(3):298-307.
Score: 0.018
-
Autologous CD34+ Cell Therapy for Refractory Angina: 2-Year Outcomes From the ACT34-CMI Study. Cell Transplant. 2016; 25(9):1701-1711.
Score: 0.018
-
Ixmyelocel-T for patients with ischaemic heart failure: a prospective randomised double-blind trial. Lancet. 2016 Jun 11; 387(10036):2412-21.
Score: 0.018
-
The ixCELL-DCM Trial: Rationale and Design. Cell Transplant. 2016; 25(9):1689-1699.
Score: 0.018
-
Impact of a novel interventional platform and hospital design on the door-to-balloon time in patients presenting with ST-segment elevation myocardial infarction. Crit Pathw Cardiol. 2015 Mar; 14(1):39-43.
Score: 0.017
-
A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: design of the RENEW study. Am Heart J. 2013 Jun; 165(6):854-861.e2.
Score: 0.015
-
An open-label dose escalation study to evaluate the safety of administration of nonviral stromal cell-derived factor-1 plasmid to treat symptomatic ischemic heart failure. Circ Res. 2013 Mar 01; 112(5):816-25.
Score: 0.014
-
Outcomes of unselected recipients of sirolimus-eluting stents: the Cypher stent U.S. post-marketing surveillance registry. J Invasive Cardiol. 2010 Feb; 22(2):48-55.
Score: 0.012
-
Long-term (2-year) clinical events following transthoracic intramyocardial gene transfer of VEGF-2 in no-option patients. J Interv Cardiol. 2005 Feb; 18(1):27-31.
Score: 0.008
-
Clinical and angiographic profile of patients with markedly elevated coronary calcium scores (>or=1000) detected by electron beam computed tomography. Cardiovasc Radiat Med. 2004 Jul-Sep; 5(3):109-12.
Score: 0.008
-
Usefulness of beta radiation for de novo and in-stent restenotic lesions in saphenous vein grafts. Am J Cardiol. 2003 Aug 01; 92(3):312-4.
Score: 0.007
-
Aortic homograft endocarditis caused by Rhodotorula mucilaginosa. Infection. 2003 Jun; 31(3):181-3.
Score: 0.007
-
Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction. J Am Coll Cardiol. 2002 Dec 04; 40(11):1928-34.
Score: 0.007
-
Clinical outcomes of patients treated with the cutting balloon and Sr-90 beta-irradiation for instent restenosis. Cardiovasc Radiat Med. 2002 Jan-Mar; 3(1):12-5.
Score: 0.007
-
Percutaneous transmyocardial laser revascularisation for severe angina: the PACIFIC randomised trial. Potential Class Improvement From Intramyocardial Channels. Lancet. 2000 Nov 18; 356(9243):1705-10.
Score: 0.006
-
Poloxamer-188 as an adjunct to primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol. 1996 Oct 01; 78(7):747-50.
Score: 0.005